1-3 of 3
Rebecca Kruse-Jarres
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Real-world impact of emicizumab and immunosuppression on acquired hemophilia A: a multicenter US cohort

Jacqueline N. Poston, Cassandra Bryan, Annette von Drygalski, Kadhim Al Banaa, Jenny Y. Zhou, Aric Parnes, Evan C. Chen, Osman Khan, Patrick Ellsworth, Lorraine Cafuir, Christopher Walsh, Miguel A. Escobar, James F. Wu, Lynn M. Malec, Craig M. Kessler, Maissaa Janbain, Rebecca Kruse-Jarres
Journal: Blood Advances
Blood Adv (2024) 8 (22): 5896–5905.
https://doi.org/10.1182/bloodadvances.2024013882
Published: 2024
Includes: Supplemental data
Journal Articles

Surgical outcomes in people with hemophilia A taking emicizumab prophylaxis: experience from the HAVEN 1-4 studies

Rebecca Kruse-Jarres, Flora Peyvandi, Johannes Oldenburg, Tiffany Chang, Sammy Chebon, Michelle Y. Doral, Stacy E. Croteau, Thierry Lambert, Christine L. Kempton, Steven W. Pipe, Richard H. Ko, Benjamin Trzaskoma, Christophe Dhalluin, Nives Selak Bienz, Markus Niggli, Michaela Lehle, Ido Paz-Priel, Guy Young, Víctor Jiménez-Yuste
Journal: Blood Advances
Blood Adv (2022) 6 (24): 6140–6150.
https://doi.org/10.1182/bloodadvances.2022007458
Published: 2022
Includes: Supplemental data
Journal Articles

Autoimmune- and complement-mediated hematologic condition recrudescence following SARS-CoV-2 vaccination

Clinical Trials & Observations
Andrew Jay Portuguese, Cassandra Sunga, Rebecca Kruse-Jarres, Terry Gernsheimer, Janis Abkowitz
Journal: Blood Advances
Blood Adv (2021) 5 (13): 2794–2798.
https://doi.org/10.1182/bloodadvances.2021004957
Published: 2021